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The expiry date of man: a synthesis of
evolutionary biology and public health
Luc Bonneux, Jan J Barendregt, Paul J Van der Maas
Abstract
In industrialised countries, mortality and
morbidity are dominated by age related
chronic degenerative diseases. The health
and health care needs of future popula-
tions will be heavily determined by these
conditions of old age. Two opposite sce-
narios of future morbidity exist: morbid-
ity might decrease (“compress”), because
life span is limited, and the incidence of
disease is postponed. Or morbidity might
increase (“expand”), because death is
delayed more than disease incidence.
Optimality theory in evolutionary biology
explains senescence as a by product of an
optimised life history. The theory clarifies
how senescence is timed by the competing
needs for reproduction and survival, and
why this leads to a generalised deteriora-
tion of many functions at many levels. As
death and disease are not independent,
future morbidity will depend on duration
and severity of the process of senescence,
partly determined by health care, palliat-
ing the disease severity but increasing the
disease duration by postponing death.
Even if morbidity might be compressed,
health care needs will surely expand.
(J Epidemiol Community Health 1998;52:619–623)
In this article, we discuss expectations of future
mortality, morbidity, and health care costs in
developed countries with high levels of health
and health care. The use of such expectations
include estimating future demands for health
care, identifying the types of services to be pro-
vided (for example, hospital care, nursing care,
or other types of institutional care) and
determining the prevalence and range of
disabilities that exist in a population, to
mention a few.1 Examples abound of the uses of
forecasts of the size and health status of the
population for health policy planning. Particu-
larly the expected increases in chronic condi-
tions of old age such as dementia, hip fractures,
or heart failure are a matter of concern.2–4 The
projected growth of the elderly population,
those aged 75 and older, caused both by high
birth rates in the past and increased survival
now and in the future is the main determinant
of escalating needs for long term care.3 As
nearly all future residents of nursing homes and
suVerers from disabling diseases of old age
between now and 2060 have already been
born, forecasts of the size of the health care
needs of the elderly population rely heavily on
estimates of future survival, and the health sta-
tus of those surviving. Such long term forecasts
of future morbidity and mortality are to be
based on an understanding of age related
disorders. Why does aging, or better senescing,
happen?5
The hallmark of senescence is the progres-
sive increase in age specific death rates follow-
ing puberty, observed in all mammals and
many other species kept under conditions ideal
for survival.6–8 Underlying this progressive
increase is a generalised deterioration in a
broad spectrum of physiological and metaboli-
cal functions.9 10 These physiological decre-
ments leave the organism increasingly vulner-
able to a variety of intrinsic and extrinsic
factors that may cause disease, disability, and
death. The evolutionary theory of aging
explains senescence as a process tailored by
natural selection in evolutionary time.
In this paper we will first explain the funda-
mentals of evolutionary theory. Then we
discuss consequences for future public health.
A history of life and death
Neo-Darwinian evolutionary theory states
that the human genome is the result of the
forces of natural selection through evolution-
ary time scales.11 The evolutionary success of a
species is determined by the “fitness” of its
individuals, the increase or decrease of num-
bers of descendants through successive
generations.12 13
“GENETIC NEGLECT”
Figure 1 shows the mortality history of Dutch
men and women in the 20th century. While the
life expectancy increased tremendously, the age
dependent mortality changes are remarkably
similar in all periods.5 Child mortality is
highest immediately after conception, and
decreases to low levels at the end of childhood
and the beginning of puberty. Even in the
darkest of ages and the harshest of conditions,
all our forefathers and foremothers succeeded
to reach adulthood and have at least one child.
Not a single one in our long line of ancestors
died in infancy or childhood. Genes command-
ing juvenile survival must be very good
indeed.14
But after the onset of puberty the cumulative
probability of both successful reproduction and
(violent) death is increasing. In natural condi-
tions the mortality hazard is high, and relatively
constant over age. The probability that a
person would be dead—from hunger, injury,
infection or predation—increases sharply by
age, long before old age is reached. The power
of natural selection, weeding out detrimental
mutations, is consequently decreasing. Genes
protecting survival at older ages are not
selected for, because aging is rare, and
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inconsequential to production and survival of
oVspring.6 Evolution does not care about
elderly.
This is the central pillar of any evolutionary
theory of aging: with or without senescence,
the length of life is limited.6 15 16 In natural con-
ditions mortality from hunger, injury, infection
or predation is so high, that few individuals
survive into old age.
A BODY IS A DISPOSABLE GOOD
There is an additional reason why senescence
exists. Millions of years of ruthless competition
have optimised the life history of a species.16–18
Food (energy) is nearly always in short supply.
Given similar physiologies and environmental
constraints, the organism that makes the most
of scarce resources, will have the stronger line-
age of successful descendants. There are
choices to be made between investing resources
in reproduction or survival.9 15 16
Some species invest in much oVspring early
in life, but at the price of high mortality and
short life spans. Others adopt a caring strategy:
they live long, but reproduce late and little.
Homo sapiens is the ultimate carer among
mammals. His very long life span is related to
his very long youth, which again is related to
the large size of his brains.7 19 20 The larger the
brain is, the longer education and parental care
is needed to make use of its full potential.7 But
after the oVspring is able to fend for himself,
the parent is disposable from the point of view
of natural selection.
The alternative name of the optimality
theory of senescence, the “disposable soma”
theory, refers to the disposable goods from
economy.9 16 An optimal product takes into
account the expected duration of use of that
product. It is a waste of resources to invest in
increased durability beyond that duration. For
animals that is the natural life expectancy in the
wild.21 Organisms who succeed in diverting this
energy to more successful reproduction will
outcompete the more wasteful. Fitness—that
is, successful oVspring—not survivorship, de-
termines evolutionary success.
Optimality theory is consistent with other,
non-evolutionary, theories of aging. The evolu-
tion theory gives an “ultimate” explanation,
why stochastic “wear and tear” and/or somatic
damage such as oxidative stress by free radicals
cause senescence.21–23 Lasting damage is not
inevitable: living beings are dynamic systems,
capable of maintenance and repair. Damage
happens because maintenance and repair
become increasingly less eVective at older ages,
when the body is disposable.
THEORIES OF ADAPTATION
The previous explanations of senescence are
called non-adaptive. Animals are not selected
“because” they senesce. Senescence is a by
product of lack of selection pressure and an
optimal life history. Alternative theories state
that senescence can be adaptive; they are based
on an argument of crowding. “Groups” are
selected for senescence, because the older indi-
viduals are discarded, and leave room for the
healthy young. Firstly, there is a circularity in
this argument: the reason why the old are
unhealthy and subfertile is because they
senesce. Next, if the circularity is excluded by
stating that the old are as healthy and as fertile
as the young, it is hard to see how these groups
might be disadvantaged, compared with groups
with unhealthy elderly.
Based on theories of adaptation the existence
of “suicide genes” can be predicted, genes that
actively programme the end of life. This is
unlikely for the same reason: there would be
strong selection pressure for mutations deleting
these genes. At least in the short-term, these
immortal (healthy and fertile) “escape mu-
tants” would outcompete the aging mortals in
numbers of oVspring. Such escape mutants
have never been observed in nature.
Disability and death from evolutionary
perspective
Optimality theory states that the age depend-
ent occurrence of degenerative diseases is
timed by the life history of our ancestors.
Energy consuming maintenance systems at
multiple levels, from subcellular DNA-repair
to normal functioning of the brain, will assure
more or less the same life span.8–10 This implies
that diseases caused by senescence are timed
by the same process. The distinction between
fatal and disabling conditions only makes sense
in human societies: in natural conditions, a
disabled hunter has few chances for survival. If
one of the systems is set too “low”, and fails
consistently too soon, natural selection will
tend to increase the level at which the system is
set. If persons prone to early cancer have less
oVspring or less opportunity to rear them suc-
cessfully, their genes will disappear. But
conversely, if one of the systems is set too high,
and would never fail during a normal lifetime,
natural selection will tune it down. The saved
resources are, in terms of natural selection,
better used to boost fitness. The optimal
balance between spending “enough” and
spending “too much” in survival is not very
sharp.21 Selection pushes survival to an opti-
mum, but the pressure is weaker the more this
optimum is approached. This allows for
Figure 1 Death rates by sex, age, and three time periods in the 20th century.
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considerable variance of senescence rates. Not
all people age at the same rate, and not all sys-
tems of an individual deteriorate at the same
rate.
The future of death
As mentioned in the introduction, estimates of
the future size of the population of elderly in
the foreseeable future are nearly entirely deter-
mined by their survival. Figure 2 shows the
stationary life table populations of women of
two periods, 1950–54 (age standardised mor-
tality 0.0104/y, life expectancy 73 years),
1985–89 (age standardised mortality 0.0062/y,
life expectancy 80 years) and of a hypothetical
period with a life expectancy of 85 year (age
standardised mortality 0.0038/y). When the
mortality would decline at the same (age
specific) rate as between 1950–54 and 1985–
89, this hypothetical life expectancy and
mortality would occur in the period 2020–24.
The stationary life table population assumes
that all birth and death rates remain constant at
the level of a certain period. In 1950–54, when
the life expectancy was 73 years, 6.6% of the
life table population was over 75 years and
1.2% over 85 years old. In 1985–89, at a life
expectancy of 80 years, 10.5% was over 75 and
3.1% over 85. In 2020–24, at a projected life
expectancy of 85 years, an estimated 14.0%
would be over 75 and 5.3% over 85. In the
Netherlands in 1994, the population of 75 and
older comprised 5.5% of the population; this
fraction is relatively low as a consequence of the
large baby boom cohort that occurred after the
second world war. However, these 5.5%
consumed 28.8% of all health care costs.24 In
2020 the survivors of the baby boom cohorts
will start reaching 75 years, their ultimate size
being determined by the mortality decline in
elderly populations, as mortality among the
young and adult is already very low. To be
valid, any prediction of further declines in
death rates rates should therefore involve a
theory about senescence.
Based on evolutionary theory, we can make
predictions about senescent death. Death is not
“programmed” by death genes, but the result
of a general neglect of the genetic material at
older ages, both by lack of historical selection
pressure and by imperfect maintenance. Life
span is not fixed by “hard” programmed limits,
but by “soft” probabilistic limits, a result of
genetic variance and stochastic accumulation
of damage.25 Major breakthroughs in “genetic
engineering” of senescent mortality are very
unlikely, as the number of genes involving
maintenance at multiple levels is large and the
potential for synergy immense.26 Opportunities
for slowing the rate of senescence are to be
sought in decreasing the rate of accumulation
of damage, which is identical to a familiar con-
cept to public health practitioners and epide-
miologists: diminishing exposure to risk fac-
tors.
The question how much mortality reduction
can be obtained by further risk factor reduc-
tions is not without answers. With the notable
exception of smoking,27 simple risk factor
models building on classic epidemiological
techniques show but modest extensions of life
expectancy by risk factor reduction, in the
order of magnitude of one to a few years.28 29
More complex multivariate models, using lon-
gitudinal data of the Framingham Heart Study,
arrived at similar results.30 Predictions of
“natural” life expectancies of more than 95
years and life spans of over 130 years are based
on few and hard to verify observations of
extinct cohorts born before 1880 and many
assumptions about the “tail” of the distribution
of deaths at ages above 110.31 The probabilistic
nature of the end of life, predicted by
evolutionary theory, foresees a long tail of
scarce survivors reaching extreme old age, but
the population life expectancy is little sensitive
to these small numbers.
Another approach to the problem of an
uncertain future is to study the recent past, and
extrapolate the changes needed to reach a cer-
tain life expectancy.32 Figure 1 showed the evo-
lution of mortality in the 20th century by age
(since 1900), figure 3 by cause of death (since
1950) in the Netherlands.
During the first half of the century, mortality
declined predominantly during childhood and
adulthood of both men and women, the
changes in middle age being more modest. In
the third quarter of the century, the diVerence
between men and women is astonishing. Men
Figure 2 Survival in period life tables of Dutch women in
1950–54 (life expectancy 73 years), in 1985–89 (life
expectancy 80 years) and after projecting the age specific
mortality decline between 1950–1989 till 2020–24 (life
expectancy 85 years).
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KEY POINTS
x The key element of the evolutionary
theories of aging is that after successful
reproduction repair and maintenance of
the genome is neglected.
x Because senescence is a consequence of
general neglect, many genes and more
processes are involved in the decay of the
organism.
x Major breakthroughs in the reduction of
mortality are unlikely, and future gains in
life expectancy will be limited.
x Non-fatal and fatal diseases of old age
have been equally timed by the same
forces of natural selection.
x Delay of death by fatal diseases will result
in the emergence of non-fatal diseases in
the gained life years.
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experienced increasing cardiovascular disease
and cancer mortality, caused by coronary heart
disease and smoking induced respiratory can-
cers, while among women death rates de-
creased from all causes. The most recent
period shows again striking changes in the sex
diVerences, but now in opposite directions.
Among men, cardiovascular mortality is going
down rapidly, and cancer mortality seems to
have reached its peak, and starts declining now.
But among women, the mortality decline is
leveling oV since 1980; from 1950 till 1980, age
standardised mortality decreased by 1.5% per
year, from 1980 till 1992 by 0.6% per year. The
decrease in cardiovascular mortality slowed
down.33 Cancer and respiratory disease mor-
tality have been stagnating for a long period,
and all other causes are increasing, as among
men. To increase the actual life expectancy
among women from 80 (80.3 years in 1994) to
85 years, all cardiovascular mortality (the only
declining cause of death since 1980) has to be
eradicated, or alternatively the present down-
ward trend in mortality from all causes (an
annual decline of 0.6%) has to persist for the
next 85 years.
Obviously, the recent mortality experience of
Dutch women does not necessarily mirror the
experience of all women of the developed
world. Indeed, one study, reconstructing mor-
tality and census counts of four racial/ethnic
populations in the USA, showed that female
immigrants of Asian/Pacific origin have
reached a life expectancy of even more than 85
years.34 However, migrant populations are a
healthy selection of the population of origin,
even more so because USA immigration laws
only allowed the highly educated and healthy.
Secondly, moribund immigrants may return to
their country of origin to die, biasing death
counts. Thirdly, exaggeration of age is preva-
lent in most human societies; the majority of
Asian migrants are foreign born, and their
exact birth year is not known.35 36 Fourthly, the
actual period life table is the result of the low
mortality hazard of modern time, applied to
the selected survivors of past (higher) mor-
tality. An earlier demographic transition37 and a
lower historical mortality might explain the
stagnating increase of life expectancy, also
observed in other highly developed countries
such as the Scandinavian countries.38 Higher
(period) life expectancies are possible in socie-
ties moving more rapidly through the epide-
miological transition, but only for a while. As
the birth cohorts exposed to the high pre-
transitional death rates die out, the high
mortality selection early in life will disappear.
The recent mortality experience of elderly in
27 developed countries showed a steady and
unprecedented decline between the 1960s and
1980s.36 However, this mortality decline was
observed in cohorts of survivors exposed to the
high child mortality in the 19th century and
mostly before reaching life expectancies of 80
and higher. The (relative) mortality decline,
particularly among women, tapered oV with
age, as expected when the end of life is
programmed by a “soft” probabilistic limit.25
The life expectancy of 85 years for Dutch
women in 2020–24 (fig 2) was reached by pro-
jecting this historically steep mortality decline
between 1950–54 and 1985–89 among
women, and ignored largely the levelling oV in
the most recent period. If we project the period
1985–1994, it will take nearly a century before
life expectancy of Dutch women reaches 85
years. So for the foreseeable future (female) life
expectancies above 85 seem unlikely in the
Netherlands. In selected populations, and in
populations moving rapidly through the demo-
graphic transition, higher period life expectan-
cies are possible at the end of the transition, but
only for a while. While among hunter gatherers
grandparents are useful to their genetic oV-
spring because of the prolonged period of juve-
nile dependence,39 the maintenance schedule
of Homo sapiens does not foresee great-
grandparents.
Compressing disability, expanding health
care needs?
The mortality trends from the recent past
among Dutch women are insuYcient to reach a
life expectancy of 85 years within a half
century. However, even moderate increases in
life expectancy will sharply increase numbers
of elderly, as we showed previously. The next
question is how healthy or disabled these future
populations will be.
The question if and how senescent disability
among these elderly will change depends basi-
cally on the equilibrium of three forces. The
first force slows the rate of senescence,
decreases incidence, and “compresses” senes-
cence until old age. The second force decreases
the mortality hazard, increases disease dura-
tion, and expands senescence. Disability and
death at old age are timed by the same process,
and successfully postponing death from one
cause will increase disability from other causes.
And the often forgotten third force “com-
presses” morbidity, not by reducing the num-
bers but by reducing the severity of disease: by
successfully preventing, treating or palliating
disability. There is consequently a paradoxical
relation between disability and health care
need. Actual disability is the disability not pre-
vented and not palliated. One of Fries’ prime
examples of compression of disease, stroke, has
been brought about in part by health care,
namely treatment of hypertension, which costs
Figure 3 Death rates by sex, time period, and cause of death since 1950.
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1.3% of the total Dutch health care
budget.24 40 41 Historically, it is reasonable to
assume that the epidemiological transition
causes both decreasing mortality and decreas-
ing disability as most of the transition is caused
by prevention of infectious diseases.42 43 How-
ever, in the fourth phase of the transition, the
age of delayed degenerative disease,44 health
care is one of the prime forces of change. The
eVects of health care on disability are mixed:
health care increases disability by delaying
(cardiovascular) death, decreases severity by
palliating disease symptoms, and prevents dis-
ability by treating risk factors such as diabetes
mellitus, hypertension, and cholesterol. So it is
no surprise that disability free life expectancy is
increasing and age adjusted disability trends in
elderly are still decreasing in the fourth phase
of the transition.45 However, if life expectancy
increases further, senescent diseases, timed by
the same evolutionary forces as senescent
death, are uncovered. Health care needs will
increase to reduce the ensuing disability. If and
how disability will compress, will depend
mainly on the eVectivity of that health care, but
there is little doubt that health care needs will
increase.
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